Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
5 results
  • Breast Cancer, Metastatic/Advanced Cancer, Melanoma, Merkel Cell Carcinoma, Head and Neck Cancer

17-334          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation Study or MRNA-2416, A Lipid Nanoparticle Encapsulated MRNA Encoding Human OX4OL, For Intratumoral Injection to Patients with Advanced Malignancies (View details on clinicaltrial.gov)

  • Melanoma, Sarcoma, Colorectal Cancer, Merkel Cell Carcinoma

17-288          Phase I

A Phase 1/1b first-in-human dose escalation and expansion study for the evaluation of safety, pharmacokinetics, pharmacodynamics and anti-tumor activity of SAR439459 administered intravenously as monotherapy and in combination with REGN2810 in adult patients with advanced solid tumors (View details on clinicaltrial.gov)

  • Breast Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Merkel Cell Carcinoma

18-051          Phase I

A Phase 1a/1b Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors (View details on clinicaltrial.gov)

  • Merkel Cell Carcinoma, Melanoma

19-446          Phase II

A phase 1b/2a, open label study to evaluate anti-tumor efficacy and safety of rhIL-7-hyFc (NT-I7) in combination with anti-PD-L1 (atezolizumab) in patients with anti-PD-1/PD-L1 naïve or relapsed/refractory high-risk skin cancers (View details on clinicaltrial.gov)

  • Merkel Cell Carcinoma

19-712          Phase III

A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma (View details on clinicaltrial.gov)

Showing 1 - 10 of 5 results